- Home
- ARDX vs JBGS Comparison
ARDX vs JBGS Comparison
Compare ARDX & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- JBGS
- Stock Information
- Founded
- ARDX 2007
- JBGS 2016
- Country
- ARDX United States
- JBGS United States
- Employees
- ARDX N/A
- JBGS N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- JBGS Real Estate Investment Trusts
- Sector
- ARDX Health Care
- JBGS Real Estate
- Exchange
- ARDX Nasdaq
- JBGS Nasdaq
- Market Cap
- ARDX 1.3B
- JBGS 1.3B
- IPO Year
- ARDX 2014
- JBGS 2017
- Fundamental
- Price
- ARDX $3.39
- JBGS $16.44
- Analyst Decision
- ARDX Strong Buy
- JBGS Sell
- Analyst Count
- ARDX 8
- JBGS 2
- Target Price
- ARDX $10.19
- JBGS $16.00
- AVG Volume (30 Days)
- ARDX 6.4M
- JBGS 1.3M
- Earning Date
- ARDX 05-01-2025
- JBGS 04-29-2025
- Dividend Yield
- ARDX N/A
- JBGS 4.35%
- EPS Growth
- ARDX N/A
- JBGS N/A
- EPS
- ARDX N/A
- JBGS N/A
- Revenue
- ARDX $361,706,000.00
- JBGS $520,825,000.00
- Revenue This Year
- ARDX $15.74
- JBGS N/A
- Revenue Next Year
- ARDX $34.56
- JBGS N/A
- P/E Ratio
- ARDX N/A
- JBGS N/A
- Revenue Growth
- ARDX 127.33
- JBGS N/A
- 52 Week Low
- ARDX $3.62
- JBGS $13.28
- 52 Week High
- ARDX $9.20
- JBGS $18.86
- Technical
- Relative Strength Index (RSI)
- ARDX 28.22
- JBGS 61.45
- Support Level
- ARDX $3.50
- JBGS $16.03
- Resistance Level
- ARDX $3.72
- JBGS $16.73
- Average True Range (ATR)
- ARDX 0.26
- JBGS 0.61
- MACD
- ARDX -0.13
- JBGS 0.20
- Stochastic Oscillator
- ARDX 0.63
- JBGS 87.54
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in and develops real estate assets concentrated in urban infill submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to the legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily and third-party asset management and real estate services. The company generates majority of its revenue from Commercial segment.